| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |